Elevance Health Inc.

NYSE:ELV

Medical - Healthcare Plans

Healthcare
$400.84 -0.88%

-$3.45 today

Market cap
$86.60B
Beta
0.68
P/E (TTM)
16.3
EPS (TTM)
$23.78
Dividend yield
1.77%
52W Low $273.71High $426.98

Volume 1.91M

Average 1.68M

ELV Other Financing Activities

Financing cash flows not reported separately.

Elevance Health Inc.NYSE: ELV

Other Financing Activities · Q3 FY2026 · quarter ended Sep 2026

Other financing activities growth accelerates

Q3 FY2026 other financing activities of $1.52B rose 982.9% year over year, ahead of the -35.9% change in trailing-twelve-month other financing activities. Over 3 fiscal years it compounded at -45.7% a year.

Context

  • Other financing activities amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Other financing activities increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +982.9% holds above the trailing-twelve-month pace of -35.9%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
$1.52B+448.5% QoQ
Last fiscal yearDec 2025
$69M+76.9% YoY
LTMSep 2026
$225M-35.9% YoY
Other Financing Activities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+982.9%——
1 year+76.9%——
3-year CAGR-45.7%——
5-year CAGR——
10-year CAGR——

Other Financing Activities history

USD · from the cash flow

Latest · FY2025
69M USD
Year-over-year change
+76.9%
4-year CAGR
-49.8%

Other Financing Activities vs competitors

How ELV compares with its peers on the latest reported figures

  • ELV's LTM Sep 2026 other financing activities of $225M is the 4th largest of the 9 companies compared; the peer median is $5.83M.
  • Its year-over-year change of -35.9% is the 7th highest of 9, against a peer median of +3.2%.
  • Other financing activities amounts to 0.1% of revenue for ELV, versus a peer median of 0.1%.
ELV Competitors Peer median
Other Financing Activities for ELV and competitors
Company Period LTM YoY 3-year CAGR% of revenue
UNHUnitedHealth Group IncorporatedLTM Sep 2026$8.14B +186.8%-31.7%1.8%
HUMHumana Inc.LTM Sep 2026$2.49B +203.8%—1.6%
CICigna CorporationLTM Sep 2026$798M +14.5%+109.5%0.3%
ELVElevance Health Inc.LTM Sep 2026$225M -35.9%-45.7%0.1%
CVSCVS Health CorporationLTM Jun 2026$204M -232.5%+167.9%0.0%
MOHMolina Healthcare, Inc.LTM Sep 2026$23M -8.0%-42.0%0.1%
CNCCentene CorporationLTM Jun 2026$10M -28.6%-22.6%0.0%
OSCROscar Health, Inc.LTM Jun 2026$6.81M +397.5%-8.0%0.0%
ALHCAlignment Healthcare, Inc.LTM Mar 2026$1.66M -1385.3%-82.9%0.0%
Peer median (excluding ELV) $5.83M+3.2%-22.6%0.1%

Competitors are the stored peer set for ELV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income6.1B6.02B5.99B5.97B5.66B
Depreciation & Amortization1.3B1.68B1.75B1.39B1.55B
Deferred Income Tax173M(76M)(602M)(374M)(279M)
Stock-Based Compensation255M264M289M191M276M
Change in Working Capital784M253M(535M)(1.72B)(3.28B)
Accounts Receivables(2.14B)(2.51B)(1.76B)(683M)(2.53B)
Inventory2.14B2.51B000
Accounts Payables719M252M1.64B(272M)(720M)
Other Working Capital65M1M(413M)(764M)(31M)
Other Non-Cash Items(245M)264M1.18B346M363M
Operating Cash Flow8.36B8.4B8.06B5.81B4.29B
Capital Expenditures(1.09B)(1.15B)(1.3B)(1.26B)(1.12B)
Acquisitions (Net)(3.48B)(649M)(1.55B)(4.45B)88M
Purchases of Investments(18.67B)(24.95B)(16.24B)(17.99B)(15.03B)
Sales of Investments14.61B22.61B13.54B18.57B15.1B
Other Investing Activities(1.02B)(421M)(24M)(51M)(385M)
Investing Cash Flow(9.64B)(4.56B)(5.57B)(5.17B)(1.34B)
Debt Repayment2.34B1.8B739M5.56B2.33B
Common Stock Issued00000
Common Stock Repurchased(1.9B)(2.32B)(2.68B)(2.9B)(2.61B)
Dividends Paid(1.1B)(1.23B)(1.4B)(1.51B)(1.53B)
Other Financing Activities1.08B432M(17M)39M69M
Financing Cash Flow423M(1.32B)(3.35B)1.19B(1.74B)
Effect of Forex Changes(10M)(14M)(1M)(72M)(5M)
Net Change in Cash(861M)2.51B(861M)1.76B1.2B
Free Cash Flow7.28B7.25B6.77B4.55B3.17B

Elevance Health Inc.

NYSE:ELV

Intrinsic Alpha fair value

Locked

Current Price

$400.84

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.